Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Euronext Bruxelles  >  Ablynx    ABLX   BE0003877942

ABLYNX (ABLX)
Mes dernières consult.
Most popular
  Report  
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
 News SummaryMost relevantAll newsofficial PublicationsSector newsTweets
Most relevant news about ABLYNX
04/24ABLYNX : 24/04/2018 publication in accordance with article 14 of the belgian law..
PU
04/24ABLYNX : Publication in accordance with article 14 of the belgian law of 2 may 2..
GL
04/19ABLYNX : 19/04/2018 publication in accordance with article 14 of the belgian law..
PU
04/19ABLYNX : Publication in accordance with article 14 of the belgian law of 2 may 2..
GL
04/19ABLYNX : Publication in accordance with article 14 of the belgian law of 2 may 2..
GL
04/17Sanofi in talks to sell generics arm to Advent for 1.9 billion euros
RE
04/17ABLYNX : 17/04/2018 publication in accordance with article 14 of the belgian law..
PU
04/17ABLYNX : Publication in accordance with article 14 of the belgian law of 2 may 2..
GL
04/17ABLYNX : Publication in accordance with article 14 of the belgian law of 2 may 2..
AQ
04/17ABLYNX : Threshold crossings
CO
04/12ABLYNX : 12/04/2018 publication in accordance with article 14 of the belgian law..
PU
04/12ABLYNX : Publication in accordance with article 14 of the belgian law of 2 may 2..
GL
04/12ABLYNX : Publication in accordance with article 14 of the belgian law of 2 may 2..
GL
04/12ABLYNX : Publication in accordance with article 14 of the belgian law of 2 may 2..
AQ
04/11ABLYNX : Threshold crossings
CO
More most relevant news
All news about ABLYNX
04/24ABLYNX : 24/04/2018 publication in accordance with article 14 of the belgian law..
PU
04/24ABLYNX : Publication in accordance with article 14 of the belgian law of 2 may 2..
GL
04/19ABLYNX : 19/04/2018 publication in accordance with article 14 of the belgian law..
PU
04/19ABLYNX : Publication in accordance with article 14 of the belgian law of 2 may 2..
GL
04/19ABLYNX : Publication in accordance with article 14 of the belgian law of 2 may 2..
GL
04/17Sanofi in talks to sell generics arm to Advent for 1.9 billion euros
RE
04/17ABLYNX : 17/04/2018 publication in accordance with article 14 of the belgian law..
PU
04/17ABLYNX : Publication in accordance with article 14 of the belgian law of 2 may 2..
GL
04/17ABLYNX : Publication in accordance with article 14 of the belgian law of 2 may 2..
AQ
04/17ABLYNX : Threshold crossings
CO
More news
Sector news : Biotechnology & Medical Research - NEC
04/25Currency and pricing squeeze GSK as new shingles vaccine shines
RE
04/19Novartis CEO feels heat on U.S. generics, Cosentyx drop
RE
04/17GE rides gene therapy wave with ready-made viral drug factories
RE
04/12GSK slims portfolio with sale of rare disease gene therapy drugs
RE
04/12UK gene therapy firm Orchard plans stock offer after GSK deal
RE
04/12TAKEDA SOUNDS OUT BANKS FOR LOANS AS : sources
RE
More sector news : Biotechnology & Medical Research - NEC
Official Publications
04/17Threshold crossings 
04/11Threshold crossings 
04/10Proxy Statments 
04/10Threshold crossings 
04/06Threshold crossings 
04/05Threshold crossings 
More official Publications
News from SeekingAlpha
03/26Ablynx's vobarilizumab flunks mid-stage lupus study 
03/02Mid-stage study underway in Japan for Ablynx ALX-0171 in RSV 
02/22Ablynx NV reports FY results 
01/30YOUR DAILY PHARMA SCOOP : Sanofi To Acquire Ablynx, PTC Therapeutics Announces D.. 
01/22ABLYNX : Novo Offer Undervalues The Company 
01/20YOUR DAILY PHARMA SCOOP : Ablynx Takeover Battle, Acorda Takeover Speculation, O.. 
Latest Tweets
04/24Ablynx : PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN LAW OF 2 MA.. 
04/22Ablynx’s Lock-Up Period Will Expire Tomorrow $ABLX  
04/19Ablynx : PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN LAW OF 2 MA.. 
04/17Ablynx : 17/04/2018 PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN .. 
04/12Ablynx : 12/04/2018 PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN .. 
More tweets
Qtime:38
Financials (€)
Sales 2018 64,5 M
EBIT 2018 -43,8 M
Net income 2018 -60,3 M
Finance 2018 92,1 M
Yield 2018 -
P/E ratio 2018 -
P/E ratio 2019
EV / Sales 2018 50,8x
EV / Sales 2019 20,1x
Capitalization 3 368 M
Chart ABLYNX
Duration : Period :
Ablynx Technical Analysis Chart | ABLX | BE0003877942 | 4-Traders
Technical analysis trends ABLYNX
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 5
Average target price 44,4 €
Spread / Average Target -0,90%
EPS Revisions
Managers
NameTitle
Edwin Moses Chief Executive Officer & Executive Director
Russell G. Greig Chairman
Wim Ottevaere Chief Financial Officer
Robert K. Zeldin Chief Medical Officer
Robert Freisen Chief Scientific Officer
Sector and Competitors
1st jan.Capitalization (M$)
ABLYNX116.31%4 114
CELLTRION, INC.--.--%28 789
IQVIA HOLDINGS INC-1.18%20 413
LONZA GROUP-7.22%18 571
INCYTE CORPORATION-28.05%14 432
NEKTAR THERAPEUTICS41.51%13 751